Pill Cures Monkeys with Ebola
This is a Obeldesivir news story, published by MSN.
Obeldesivir news
For more Obeldesivir news, you can click here:
more Obeldesivir newsNews about vaccine development
For more vaccine development news, you can click here:
more vaccine development newsMSN news
For more news from MSN, you can click here:
more news from MSNAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
Ebola virus. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest antiviral Obeldesivir news, vaccines news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
EbolaAFP.com
•Health
Health
Ebola-infected monkeys cured with a pill, raising hopes for humans: study
76% Informative
Ebola is a deadly viral disease spread through direct contact with bodily fluids, causing severe bleeding and organ failure.
Researchers tested the antiviral Obeldesivir , the oral form of intravenous Remdesivir .
The drug blocks an enzyme crucial for viral replication.
The study could pave the way for more practical, affordable treatments in humans.
VR Score
85
Informative language
92
Neutral language
38
Article tone
formal
Language
English
Language complexity
71
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links